Next Article in Journal
Identification of Immunogenic Epitopes That Permit the Detection of Antigen-Specific T Cell Responses in Multiple Serotypes of Group B Coxsackievirus Infections
Next Article in Special Issue
Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus
Previous Article in Journal
The E3 Ubiquitin Ligase TRIM21 Promotes HBV DNA Polymerase Degradation
Previous Article in Special Issue
Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Fluorescence Microscopy of the HIV-1 Envelope

Pablo Carravilla
José L. Nieva
3,4 and
Christian Eggeling
Institute of Applied Optics and Biophysics, Friedrich-Schiller-University Jena, Max-Wien Platz 1, 07743 Jena, Germany
Leibniz Institute of Photonic Technology, Albert Einstein Strasse 9, 07743 Jena, Germany
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), P.O. Box 644, 48080 Bilbao, Spain
Instituto Biofisika (UPV/EHU, CSIC), University of the Basque Country, E-48940 Leioa, Spain
MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford OX3 9DS, UK
Jena Center for Soft Matter (JCSM), Friedrich-Schiller-University Jena, Philosophenweg 7, 07743 Jena, Germany
Author to whom correspondence should be addressed.
Viruses 2020, 12(3), 348;
Submission received: 22 February 2020 / Revised: 19 March 2020 / Accepted: 20 March 2020 / Published: 21 March 2020
(This article belongs to the Special Issue Mechanisms of Viral Fusion and Applications in Antivirals)


Human immunodeficiency virus (HIV) infection constitutes a major health and social issue worldwide. HIV infects cells by fusing its envelope with the target cell plasma membrane. This process is mediated by the viral Env glycoprotein and depends on the envelope lipid composition. Fluorescent microscopy has been employed to investigate the envelope properties, and the processes of viral assembly and fusion, but the application of this technique to the study of HIV is still limited by a number of factors, such as the small size of HIV virions or the difficulty to label the envelope components. Here, we review fluorescence imaging studies of the envelope lipids and proteins, focusing on labelling strategies and model systems.

1. Introduction

Retroviridae family members are responsible for a high number of human diseases and conditions, and also powerful tools for gene delivery. A common feature to retroviruses is the viral envelope. It consists of a lipid bilayer that surrounds the capsid and contains the viral Env glycoprotein. The envelope components are typically acquired from the host cell plasma membrane upon viral budding. Its main functions are to define viral tropism, provide virions with a mechanism to enter target cells, and protect the viral capsid and RNA.
One of the most prominent members of the Retroviridae virus family is the Human Immunodeficiency Virus (HIV). HIV infection causes the acquired immune deficiency syndrome and is responsible for around one million deaths worldwide every year. In the case of the HIV, the Env glycoprotein is formed by the surface gp120 and transmembrane gp41 proteins. Gp120 binds to the CD4 receptor and CCR5/CXCR4 co-receptor, typically found on the membrane of T helper cells of our immune system. After receptor engagement, gp41 catalyses the fusion reaction, merging the viral lipid bilayer with the cell plasma membrane and releasing the capsid to the cytosol. Being the only viral protein exposed on virions, Env is a prime target for the immune system, although it typically fails to raise a long-lasting neutralising response during infection due to the number of immune escape mechanisms put in action by the virus. In some rare cases, the immune system is able to produce broadly neutralising antibodies [1], i.e., immunoglobulins that are able to efficiently bind to Env and block cell entry of a great variety of HIV isolates. Thus, Env has been the subject of intensive research and vaccination efforts.
Envelope lipids also present a number of unique features. Lipidomic studies provided clear evidence that the lipid composition of the viral envelope differs from that of the plasma membrane of producer cells [2,3,4,5]. The enrichment in sphingomyelin and cholesterol suggests that HIV buds from specialised nanodomains in the plasma membrane, as previously evidenced [6] and further confirmed [7,8]. In particular, cholesterol proved to be a critical lipid, since its depletion from virions inhibits HIV infectivity [9,10,11]. However, the exact inhibition mechanism is not clear yet, as viral cholesterol depletion has been reported to alter many viral features, such as membrane integrity [12], molecular order [13,14], phase properties [14] and Env stability [15]. These results suggested that the HIV membrane constitutes a functional viral component during entry. In line with this hypothesis, different membrane-targeting compounds present antiviral activity, as reviewed in [16] and [17]. Still, many open questions remain. The details of Env-mediated viral entry need to be elucidated, especially regarding the interplay between the glycoprotein and the viral membrane, and the role of the latter.
This review is focused on the application of fluorescence microscopy to the study of the HIV envelope and its role during entry and budding. Its application to virology is mainly hindered by three limitations. First, HIV virions are ca. 120 nm in diameter, which is a factor of two below the resolution limit of a conventional light microscope. This does not make HIV virions undetectable, but instead, they appear as 250 nm particles and no detail within them can be resolved, hampering their study. Second, viral entry and budding are minute-lived processes. The observation of such long phenomena often give rise to photobleaching, i.e., destruction of fluorophores, and phototoxic effects. Third, HIV virions are not fluorescent, and the introduction of fluorescence dyes can potentially alter their behaviour. Recent advances in quantitative and super-resolution microscopy, as well as design of novel fluorescent dyes will contribute to overcome these limitations, and some have already been successfully exploited in the HIV field.

2. Imaging HIV Membrane Lipids

Two types of fluorescent molecules are typically used to visualise membranes: lipid analogues and membrane dyes (Figure 1). Lipid analogues are lipids conjugated to a fluorescent dye that ideally hardly affects their usual behaviour. Analogues are widely used to image specific lipid species, but they can also be used as simple membrane stains [18]. Membrane dyes are lipophilic fluorophores that partition to lipid bilayers and permit their detection. Some of them also report on the biophysical properties of the membrane, e.g., lipid packing [19] or tension [20]. Generally, lipid analogues have been used to study viral budding and membrane dyes to investigate entry and the properties of the viral membrane, as outlined in the next paragraphs.

2.1. Imaging Lipids During HIV Assembly and Budding

The application of advanced optical microscopy to the study of HIV assembly was recently reviewed in this journal [21] and elsewhere [22,23], and instead, we will focus on the study of lipids during the process. HIV budding starts with the assembly of the structural polyprotein Gag at the inner leaflet of the plasma membrane of infected cells. The matrix (MA) domain binds to the plasma membrane inner leaflet, where it forms multimers and generates curvature, ultimately promoting virion release [24,25,26,27]. MA binds the plasma membrane through a phosphatidylinositol (4,5) biphosphate (PIP2) binding pocket and myristylation [27,28]. However, whether the unique lipid and protein composition of HIV virions arises from MA binding to pre-existing membrane domains or is actively promoted by Gag has been a matter of debate.
The existence of specialised membrane environments is widely accepted, but their nature is still under discussion, especially regarding their size and lifetime. The lipid raft hypothesis proposed that ordered membrane platforms enriched in sphingomyelin, cholesterol, and saturated lipids would create chemically distinct membrane environments denoted “lipid rafts”. For a detailed review on membrane organisation, refer to manuscripts such as those by Sezgin et al. [29] or Levental et al. [30]. It was tempting to speculate that HIV acquired its unique membrane by budding from rafts [2], further supported by the punctuate organisation of Gag at the plasma membrane [31]. However, lipid rafts have not been detected on the membrane of live untreated cells [32].
First imaging studies of Gag-lipid interactions were performed in model membranes [33,34,35,36], which constitute useful systems to address protein-lipid interactions due to their tuneable lipid composition. Gag-membrane interactions and subsequent ESCRT machinery recruitment were successfully reconstituted in giant unilamellar vesicles (GUVs) [33]. Further microscopy experiments on GUVs showed that MA binding to lipids depends on myristoylation, PIP2 and Gag multimerization [34]. Unexpectedly, MA preferentially bound to disordered “non-raft” environments, where it colocalised with different fluorescent PIP2 analogues (labelled with BODIPY TMR (BT) [34] or Top-Fluor (TF) [35]). Combined to a preferential binding to unsaturated lipid chains [36,37], Gag assembly at pre-existing lipid rafts appears unlikely. Supporting the idea of Gag actively promoting budding domains, molecular dynamics experiments using Förster resonance energy transfer (FRET) and fluorescence recovery after photobleaching (FRAP) showed that Gag induced the reorganisation of the fluorescent analogues of cholesterol (labelled with TF) (Figure 1), PIP2 (labelled with TF or BT), but not of SM (labelled with TF) [35].
Recent microscopy studies on live cells confirmed that Gag recruits proteins and lipids at budding platforms [7,8]. Super-resolution experiments (stimulated emission depletion (STED) microscopy in combination with fluorescence correlation spectroscopy (FCS), STED-FCS) in HIV-infected cells proved that fluorescent analogues of cholesterol (labelled with Abberior STAR RED via a PEG-linker) and PIP2 (PIP(4,5)2 labelled with ATTO647N) were trapped at Gag assembly sites, as opposed to fluorescent analogues of sphingomyelin (SM, labelled with ATTO647N) and phosphoethanolamine (DPPE, labelled with ATTO647N or Abberior STAR RED) (Figure 1) [8]. Gag-induced lipid platforms were independently detected at the plasma membrane of transfected cells [7], which were enriched in fluorescent analogues of cholesterol, ganglioside GM1, SM (all TF-labelled) (Figure 1), and glycophosphatidylinositol (GPI) anchored proteins (labelled with enhanced green fluorescent protein (EGFP)). In the next assembly step, these platforms promote curvature-dependent protein sorting, which would ultimately lead to the unique lipidome and proteome of the viral envelope [7].

2.2. Imaging Lipids During HIV Entry

Many membrane-targeting compounds have been shown to inhibit — or promote — HIV-1 fusion, suggesting that the viral membrane constitutes a functional element of the entry process [16,17]. Still, the exact role of lipids during HIV-1 entry is unknown [38]. To the best of our knowledge, direct imaging of viral lipid species during membrane fusion has not been reported. For a detailed review on imaging HIV entry, uncoating, and nuclear entry, the reader could refer to the manuscript by Francis and Melikyan [39]. Instead, fluorescent imaging approaches have used the lipophilic dye DiD to localise HIV virions and resolve different entry steps [40,41,42,43,44,45,46]. When combined with a second intraviral marker (e.g., the Viral Protein R (Vpr) labelled with EGFP), the fluorescence signal from membrane dyes may be employed to report on viral envelope fusion with cell membranes [40,42]. This approach was exploited to distinguish endosomal from plasma membrane fusion of HIV [42]. In the case of plasma membrane entry, the membrane signal is diluted in the immense volume of cell membranes upon fusion, as opposed to the intraviral marker that stays trapped in the core and is finally released to the cytosol [41,42]. On the other hand, during endosomal entry, the membrane dye is not diluted due to the small volume of endosomes, but the intraviral marker signal disappears after capsid release to the cytosol [42,46]. More precisely, DiD fluorescence signal lost reports on hemifusion, i.e., the merger of the external leaflets of both membranes [43]. DiD was also employed to describe the co-localisation of the HIV-1 envelope with dynamin 2 (a protein involved in the secretory pathway) at viral entry sites [44].
An alternative approach to label the HIV membrane is the use of fluorescent versions of cell proteins that are incorporated into the envelope upon budding, such as ICAM-1 [47,48,49] or the N-terminal sequence of c-Src [50]. Fluorescent proteins may be straightforwardly engineered to report on specific environmental characteristics such as pH or membrane tension and voltage, as in the case of the ecliptic pHlourin-ICAM-1 (EcpH-ICAM) chimera, which bears a pH-sensitive mutant of the green fluorescent protein (GFP) [51]. Due to pH differences, EcpH-ICAM can be used to distinguish plasma membrane from endosomal viral entry [47,48,49]. Unfortunately, a certain bias was indicated for this pH sensor to destabilise the viral membrane [49]. Bias may be general to a label, entailing independent controls for activity and functionality.

2.3. Virus and Model Membranes

The properties of the HIV-1 membrane can also be studied on immobilised virions in the absence of producer or target cells. For these experiments, viruses are immobilised on a coverslip and then imaged. The main advantage of this approach is that a very high number of virions can be acquired at the same time thus, increasing statistical value and accuracy. This approach was initially employed to probe the colocalisation of viral fluorescent proteins and cell membranes, e.g., Vpr.GFP and DiD [40,41]. In more recent studies, immobilised virions have been imaged to quantify capsid release upon envelope permeabilization [52], where membrane staining was used as a reference (either DiD or EcpH-ICAM-1).
Immobilised virions can also be employed to gain insights on the membrane biophysical properties. In a recent work, we made use of the polarity-sensitive dye Laurdan to quantify the molecular packing of the viral membrane of mature and immature immobilised HIV virions using confocal microscopy [53], similarly to previous in cuvette experiments [13]. Laurdan is a polarity-sensitive dye that changes its emission spectrum in response to solvent polarity. When incorporated into a lipid membrane, Laurdan reports on water accessibility to the membrane interior, which is determined by molecular order, i.e., lipid packing [54].
Still, fluorescence imaging of virions is generally limited by their small size below the resolution limit of conventional optical microscopes. Besides the above-mentioned super-resolution microscopy approaches, a remedy may be to extract lipids from HIV particles and reconstitute them in the form of GUVs. In a previous study, we employed this approach to study the membrane organisation of the HIV membrane and the effect of anti-viral compounds [14]. An alternative system to lipid extraction is the use of artificial model membranes, i.e., membranes made of simple lipid mixtures that resemble the chemical and biophysical properties of the HIV lipid envelope. Imaging of artificial model systems has been employed to determine lipid dynamics and molecular order of virus-like membranes [14,55,56].

3. Imaging the Envelope Glycoprotein

Imaging Env constitutes a challenging task. Adequate Env folding is very sensitive to changes in the amino acid sequence and thus, usual fluorescent protein-tagging strategies influence Env functionality and have thus so far shown limited success. Among the ca. 850 amino acids of Env, the most tolerant sequences to fluorescent protein insertion are the variable loops in gp120 (Figure 2, orange) [57]. Nakane et al. showed that GFP-opt, a derivative of superfolder GFP (Figure 2, green), can be inserted at the V4 and V5 loops while maintaining cell expression and functionality of Env in cells and virions (Figure 2) [57]. Moreover, the authors showed that this region is tolerant to the insertion of alternative fluorescent proteins such as mCherry. In another recent study, the V1/V2 variable loops were substituted by superfolder GFP, termed Env-isfGFP-ΔV1V2. Although Env-isfGFP-ΔV1V2 was unable to incorporate into virions, complementing with non-fluorescent Env-ΔV1V2 yielded fluorescent viral particles, which were significantly less infectious than virions packaging wild type Env [58]. Possibly, the main limitation to the introduction of fluorescent proteins in the Env sequence is their big size (Figure 2), which might interfere with multiple steps during entry, e.g., CD4 binding or gp41 refolding.
Antibody-labelling is another conventional strategy to label viral components. It has been broadly been employed in super-resolution microscopy studies of Env (as, for example, reviewed in [23]). The distribution of Env in assembly sites has been investigated by single molecule localisation microscopy (SMLM) to assess the role of the Env cytoplasmic domain and determine Gag-Env interactions [59,60], study the tetherin-mediated restriction of HIV release [61], and detect Env incorporation into virions [59,61]. Super-resolution STED microscopy and spectroscopy (e.g., STED-FCS, as already highlighted above) have been employed to study the maturation-dependant Env clustering [62] and mobility in single virions [53]. It must be noted that most common anti-Env antibodies origin from HIV-infected patients and neutralise Env activity, e.g., the broadly neutralising 2G12 antibody (Figure 2, blue). Thus, they can greatly affect the behaviour of Env by fixing specific structures. Introducing artificial antigen peptides in Env, such as the FLAG-tag [63], which are recognised by independent antibodies, can overcome this limitation. Anti-Env broadly neutralising antibodies themselves are also the subject of intensive research [64]. Their interaction with Env has been studied by means of STED microscopy [65] and FCS [66,67] in virions. Interestingly, some antibodies exert their neutralising activity through secondary interactions with viral lipids, which was recently studied by us using FCS on model membranes [68].
Enzymatically targeted incorporation of organic dyes constitutes an alternative bio-compatible Env-labelling strategy. Briefly, short peptide sequences are introduced in the target protein sequence. These peptides are the substrate of enzymes such as transglutaminases [69] or phosphopantetheinyl transferases [70], which catalyse bond formation between a specific amino acid within the sequence and an externally supplemented substrate, such as cadaverine or coenzyme A bound to a dye, respectively. This approach was exploited in a pioneering work where Munro et al. [71] measured the structural and conformational dynamics of native Env using single molecule Förster resonance energy transfer (FRET), monitoring fluorescence fluctuations due to distance changes between two nearby fluorescent labels (FRET label pair). Munro et al. could introduce a FRET label pair (Cy3B and Alexa Fluor 647, Figure 2) in the V1 and V4 loops of a single gp120 molecule per virus and resolve three distinct characteristic label pair distances, which corresponded to three Env conformational states [71,72,73]. Interestingly, this approach was also applicable to the study of the conformational dynamics of Influenza haemagglutinin [74] and Ebola GP glycoprotein [75].
Bio-orthogonal chemistry has also been exploited to label Env. It offers many advantages, such as high selectivity, biocompatibility and use of organic fluorescent dyes. Genetic code expansion to include non-canonical clickable amino acids at the V4 and V5 loops of Env, followed by click chemistry binding functionalised dye labels, showed specific labelling of Env at the plasma membrane of cells, although the changes in the nucleotide sequence decreased virus infectivity by one order of magnitude, probably due to lower Env incorporation efficiency [76]. Sugars of the Env glycoprotein (Figure 2, grey) can also be labelled by click chemistry [77]. Virions acquire clickable Env after the metabolic incorporation of clickable sugars into producer cells, which can subsequently be labelled with organic dyes such as Alexa Fluor 488.

4. Future Directions

HIV infection is a complex process, which is not straightforward to be imaged. Most approaches discussed in this review are greatly limited by two aspects. First, labelling the envelope components, lipids or Env, certainly alters their behaviour, e.g., even the introduction of small organic dyes decreases viral titres. Second, virions can only host a limited number of fluorescent molecules due to their small size. Added to the fact that budding and fusion span for minutes, phototoxicity and photobleaching, i.e., light-induced changes or destruction in functionality and deprivation of the whole pool of labels per virion, respectively, become serious issues that need to be circumvented.
Modern super-resolution techniques are still not perfectly suited to live cell imaging. SMLM requires acquisition times that are not always compatible with live measurements and STED microscopy may be greatly limited by photobleaching. In addition, imaging experiments may be recorded on apical cell membranes or ultimately in vivo and in tissue, i.e., the excitation and detection light beams have to travel through inhomogeneous sample regions with varying refractive indices. Such refractive index mismatch leads to distortions of the observation or focal spot (optical aberrations) and thus deteriorated image quality with respect to e.g., spatial resolution, signal-to-noise ratio and contrast, and may be compensated by improved or adaptive optics [81]. This is specifically important for super-resolution STED microscopy and STED–FCS recordings [82,83].
Another optimization step is the use of further fluorescence spectroscopy readouts such as fluorescence lifetime and anisotropy. Some commercial setups are readily implementing fluorescence lifetime imaging microscopy (FLIM) for spatially-resolved measurement of the fluorescence lifetime of fluorescent tags. Lifetime can provide additional information about the structure or environment of a fluorescent molecule and has successfully been employed in the HIV [44,46] and membrane biophysics [20] research fields. Not only established microscopy techniques are being refined, but also new ones are being developed. MINFLUX comes up as a promising solution, offering sub-nanometre localisation accuracy in live cells, while relying on low photon counts [84].
Advances in fluorescent dye design and synthesis are also providing new tools to unravel the mysteries of virus infection. With respect to new dyes, the reporting of unprecedented biophysical properties provides quantitative information about cell membranes [20], and has already been exploited in the study of HIV entry [46]. In the case of the small-sized HIV virions, exchangeable dyes constitute an interesting alternative to traditional membrane dyes, since they can circumvent photobleaching. Briefly, exchangeable membrane dyes transiently partition to lipid bilayers. Thus, the pool of fluorescent molecules at the membrane is renewed constantly as new dyes replace previously bleached ones [85,86].
In the future, sample preparation will surely evolve to increase the significance of microscopy-related findings. For example, most experiments described in this review article have been performed using the laboratory adapted strain NL4.3 (closely related to Env HXB2 sequence). This strain fails to represent most circulating isolates, presenting a lower entry efficiency and higher neutralisation susceptibility. Moreover, the majority of labelling strategies discussed above drastically decrease virus infectivity, e.g., insertion of fluorescent proteins in the Env sequence, click conjugation of dyes, or antibody staining. Future approaches will need to find minimally invasive labelling methods, for instance by identifying tolerant sites in the Env sequence. A detailed review on viral component labelling strategies was recently published by Sakin et al. [87]. Finally, most imaging studies have used artificial model systems, pseudotyped viruses, and immortal cell lines to study HIV infection. Upcoming studies will attempt to recapture the complex physiological context of HIV infection, e.g., performing experiments at 37 °C or using human primary lymphocytes.
Fluorescence microscopy of the HIV envelope is still a young field, but even if its most advanced approaches are far from being established, it has the potential to unravel many of the mysteries of HIV infection. We foresee that collaborative works between virologists, immunologists, microscopists, chemists, and biophysicist may ensure the success of this endeavour.

Author Contributions

All authors wrote the paper. PC prepared the figures. All authors have read and agreed to the published version of the manuscript.


PC was awarded a contract from the Basque Government Postdoctoral Programme (POS_2019_2_0022). JLN acknowledges financial support by the Spanish Government (BIO2015-64421-R (MINECO/AEI/FEDER UE) and RTI2018-095624-B-C21 (MCIU/AEI/FEDER UE) Grants) and the Basque Government (IT1196-19 Grant). CE acknowledges support from the Wolfson Imaging Centre Oxford (Christoffer Lagerholm), the Wolfson Foundation (18272), the Medical Research Council (MC_UU_12010/unit programmes G0902418 and MC_UU_12025), MRC/BBSRC/ESPRC (grant number MR/K01577X/1), the Wellcome Trust (104924/14/Z/14, 100262Z/12/Z, 098274/Z/12/Z and Strategic Award 091911 (107457/Z/15/Z, Advanced Micron Bioimaging Unit)), the Deutsche Forschungsgemeinschaft (Research unit 1905, Jena Excellence Cluster “Balance of the Microverse”, project no. 3162113987 – SFB 1278 (project C05), the Newton-Katip Celebi Institutional Links grant (352333122), and internal University of Oxford funding (EPA Cephalosporin Fund and John Fell Fund).


The authors would like to thank Aurélien Barbotin and Falk Schneider for helpful suggestions.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Doria-Rose, N.A.; Klein, R.M.; Manion, M.M.; O’Dell, S.; Phogat, A.; Chakrabarti, B.; Hallahan, C.W.; Migueles, S.A.; Wrammert, J.; Ahmed, R.; et al. Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies. J. Virol. 2009, 83, 188–199. [Google Scholar] [CrossRef] [Green Version]
  2. Brügger, B.; Glass, B.; Haberkant, P.; Leibrecht, I.; Wieland, F.T.; Kräusslich, H.-G.G. The HIV lipidome: A raft with an unusual composition. Proc. Natl. Acad. Sci. USA 2006, 103, 2641–2646. [Google Scholar] [CrossRef] [Green Version]
  3. Lorizate, M.; Sachsenheimer, T.; Glass, B.; Habermann, A.; Gerl, M.J.; Kräusslich, H.-G.G.; Brügger, B. Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines. Cell. Microbiol. 2013, 15, 292–304. [Google Scholar] [CrossRef]
  4. Mücksch, F.; Citir, M.; Lüchtenborg, C.; Glass, B.; Traynor-Kaplan, A.; Schultz, C.; Brügger, B.; Kräusslich, H.G. Quantification of phosphoinositides reveals strong enrichment of PIP2 in HIV-1 compared to producer cell membranes. Sci. Rep. 2019, 9, 1–13. [Google Scholar] [CrossRef]
  5. Chan, R.; Uchil, P.D.; Jin, J.; Shui, G.; Ott, D.E.; Mothes, W.; Wenk, M.R. Retroviruses Human Immunodeficiency Virus and Murine Leukemia Virus Are Enriched in Phosphoinositides. J. Virol. 2008, 82, 11228–11238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Nguyen, D.H.; Hildreth, J.E.K. Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts. J. Virol. 2000, 74, 3264–3272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Sengupta, P.; Seo, A.Y.; Pasolli, H.A.; Song, Y.E.; Johnson, M.; Lippincott-Schwartz, J. A lipid-based partitioning mechanism for selective incorporation of proteins into membranes of HIV particles. Nat. Cell Biol. 2019, 21, 452–461. [Google Scholar] [CrossRef] [PubMed]
  8. Favard, C.; Chojnacki, J.; Merida, P.; Yandrapalli, N.; Mak, J.; Eggeling, C.; Muriaux, D. HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly. Sci. Adv. 2019, 5, eaaw8651. [Google Scholar] [CrossRef] [Green Version]
  9. Campbell, S.M.; Crowe, S.M.; Mak, J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 2002, 16, 2253–2261. [Google Scholar] [CrossRef]
  10. Liao, Z.; Graham, D.R.; Hildreth, J.E.K. Lipid Rafts and HIV Pathogenesis: Virion-Associated Cholesterol Is Required for Fusion and Infection of Susceptible Cells. AIDS Res. Hum. Retroviruses 2003, 19, 675–687. [Google Scholar] [CrossRef]
  11. Campbell, S.; Gaus, K.; Bittman, R.; Jessup, W.; Crowe, S.; Mak, J. The Raft-Promoting Property of Virion-Associated Cholesterol, but Not the Presence of Virion-Associated Brij 98 Rafts, Is a Determinant of Human Immunodeficiency Virus Type 1 Infectivity. J. Virol. 2004, 78, 10556–10565. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Graham, D.R.M.; Chertova, E.; Hilburn, J.M.; Arthur, L.O.; Hildreth, J.E.K. Cholesterol Depletion of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus with β-Cyclodextrin Inactivates and Permeabilizes the Virions: Evidence for Virion-Associated Lipid Rafts. J. Virol. 2003, 77, 8237–8248. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Lorizate, M.; Brügger, B.; Akiyama, H.; Glass, B.; Müller, B.; Anderluh, G.; Wieland, F.T.; Kräusslich, H.G. Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences. J. Biol. Chem. 2009, 284, 22238–22247. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Huarte, N.; Carravilla, P.; Cruz, A.; Lorizate, M.; Nieto-Garai, J.A.; Krausslich, H.G.; Perez-Gil, J.; Requejo-isidro, J.; Nieva, J.L. Functional organization of the HIV lipid envelope. Sci. Rep. 2016, 6, 34190. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Salimi, H.; Johnson, J.; Flores, M.G.; Zhang, M.S.; Malley, Y.O.; Houtman, C.; Schlievert, P.M.; Haim, H. The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization. J. Biol. Chem. 2019, 295, 348–362. [Google Scholar] [CrossRef] [PubMed]
  16. Vigant, F.; Santos, N.C.; Lee, B. Broad-spectrum antivirals against viral fusion. Nat. Rev. Microbiol. 2015, 13, 426–437. [Google Scholar] [CrossRef]
  17. Carravilla, P.; Nieva, J.L. HIV antivirals: Targeting the functional organization of the lipid envelope. Future Virol. 2018, 13, 129–140. [Google Scholar] [CrossRef]
  18. Sezgin, E.; Schneider, F.; Galiani, S.; Urbančič, I.; Waithe, D.; Lagerholm, B.C.; Eggeling, C. Measuring nanoscale diffusion dynamics in cellular membranes with super-resolution STED–FCS. Nat. Protoc. 2019, 14, 1054–1083. [Google Scholar] [CrossRef]
  19. Owen, D.M.; Rentero, C.; Magenau, A.; Abu-Siniyeh, A.; Gaus, K. Quantitative imaging of membrane lipid order in cells and organisms. Nat. Protoc. 2011, 7, 24–35. [Google Scholar] [CrossRef]
  20. Colom, A.; Derivery, E.; Soleimanpour, S.; Tomba, C.; Molin, M.D.; Sakai, N.; González-gaitán, M.; Matile, S.; Roux, A. A fluorescent membrane tension probe. Nat. Chem. 2018, 10, 1118–1125. [Google Scholar] [CrossRef]
  21. Inamdar, K.; Floderer, C.; Favard, C.; Muriaux, D. Monitoring HIV-1 assembly in living cells: Insights from dynamic and single molecule microscopy. Viruses 2019, 11, 72. [Google Scholar] [CrossRef] [Green Version]
  22. Hanne, J.; Göttfert, F.; Schimer, J.; Anders-Össwein, M.; Konvalinka, J.; Engelhardt, J.; Müller, B.; Hell, S.W.; Kräusslich, H.G. Stimulated Emission Depletion Nanoscopy Reveals Time-Course of Human Immunodeficiency Virus Proteolytic Maturation. ACS Nano 2016, 10, 8215–8222. [Google Scholar] [CrossRef] [PubMed]
  23. Chojnacki, J.; Eggeling, C. Super-resolution fluorescence microscopy studies of human immunodeficiency virus. Retrovirology 2018, 15, 1–16. [Google Scholar] [CrossRef] [PubMed]
  24. Fäcke, M.; Janetzko, A.; Shoeman, R.L.; Kräusslich, H.G. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 1993, 67, 4972–4980. [Google Scholar] [CrossRef] [Green Version]
  25. Freed, E.O.; Orenstein, J.M.; Buckler-White, A.J.; Martin, M.A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 1994, 68, 5311–5320. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Ono, A.; Ablan, S.D.; Lockett, S.J.; Nagashima, K.; Freed, E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. USA 2004, 101, 14889–14894. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Saad, J.S.; Miller, J.; Tai, J.; Kim, A.; Ghanam, R.H.; Summers, M.F. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. USA 2006, 103, 11364–11369. [Google Scholar] [CrossRef] [Green Version]
  28. Vlach, J.; Saad, J.S. Trio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayers. Proc. Natl. Acad. Sci. USA 2013, 110, 3525–3530. [Google Scholar] [CrossRef] [Green Version]
  29. Sezgin, E.; Levental, I.; Mayor, S.; Eggeling, C. The mystery of membrane organization: Composition, regulation and roles of lipid rafts. Nat. Rev. Mol. Cell Biol. 2017, 18, 361–374. [Google Scholar] [CrossRef] [Green Version]
  30. Levental, I.; Levental, K.R.; Heberle, F.A. Lipid Rafts: Controversies Resolved, Mysteries Remain. Trends Cell Biol. 2020, 1–13. [Google Scholar] [CrossRef]
  31. Hermida-Matsumoto, L.; Resh, M.D. Localization of Human Immunodeficiency Virus Type 1 Gag and Env at the Plasma Membrane by Confocal Imaging. J. Virol. 2000, 74, 8670–8679. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Moon, S.; Yan, R.; Kenny, S.J.; Shyu, Y.; Xiang, L.; Li, W.; Xu, K. Spectrally Resolved, Functional Super-Resolution Microscopy Reveals Nanoscale Compositional Heterogeneity in Live-Cell Membranes. J. Am. Chem. Soc. 2017, 139, 10944–10947. [Google Scholar] [CrossRef] [PubMed]
  33. Carlson, L.A.; Hurley, J.H. In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters. Proc. Natl. Acad. Sci. USA 2012, 109, 16928–16933. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Keller, H.; Kräusslich, H.G.; Schwille, P. Multimerizable HIV Gag derivative binds to the liquid-disordered phase in model membranes. Cell. Microbiol. 2013, 15, 237–247. [Google Scholar] [CrossRef] [PubMed]
  35. Yandrapalli, N.; Lubart, Q.; Tanwar, H.S.; Picart, C.; Mak, J.; Muriaux, D.; Favard, C. Self assembly of HIV-1 Gag protein on lipid membranes generates PI(4,5)P2/Cholesterol nanoclusters. Sci. Rep. 2016, 6, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Olety, B.; Veatch, S.L.; Ono, A. Phosphatidylinositol-(4,5)-Bisphosphate Acyl Chains Differentiate Membrane Binding of HIV-1 Gag from That of the Phospholipase Cδ1 Pleckstrin Homology Domain. J. Virol. 2015, 89, 7861–7873. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Dick, R.A.; Goh, S.L.; Feigenson, G.W.; Vogt, V.M. HIV-1 Gag protein can sense the cholesterol and acyl chain environment in model membranes. Proc. Natl. Acad. Sci. USA 2012, 109, 18761–18766. [Google Scholar] [CrossRef] [Green Version]
  38. Chen, B. Molecular Mechanism of HIV-1 Entry. Trends Microbiol. 2019, 1–14. [Google Scholar] [CrossRef]
  39. Francis, A.C.; Melikyan, G.B. Live-cell imaging of early steps of single HIV-1 infection. Viruses 2018, 10, 275. [Google Scholar] [CrossRef] [Green Version]
  40. McDonald, D.; Vodicka, M.A.; Lucero, G.; Svitkina, T.M.; Borisy, G.G.; Emerman, M.; Hope, T.J. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 2002, 159, 441–452. [Google Scholar] [CrossRef]
  41. Markosyan, R.M.; Cohen, F.S.; Melikyan, G.B. Time-resolved Imaging of HIV-1 Env-mediated Lipid and Content Mixing between a Single Virion and Cell Membrane. Mol. Biol. Cell 2005, 16, 5502–5513. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Miyauchi, K.; Kim, Y.; Latinovic, O.; Morozov, V.; Melikyan, G.B. HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes. Cell 2009. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. De la Vega, M.; Marin, M.; Kondo, N.; Miyauchi, K.; Kim, Y.; Epand, R.F.; Epand, R.M.; Melikyan, G.B. Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion. Retrovirology 2011, 8, 99. [Google Scholar] [CrossRef] [Green Version]
  44. Jones, D.M.; Alvarez, L.A.; Nolan, R.; Ferriz, M.; Sainz Urruela, R.; Massana-Muñoz, X.; Novak-Kotzer, H.; Dustin, M.L.; Padilla-Parra, S. Dynamin-2 Stabilizes the HIV-1 Fusion Pore with a Low Oligomeric State. Cell Rep. 2017, 18, 443–453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Yang, S.-T.; Kreutzberger, A.J.B.; Kiessling, V.; Ganser-Pornillos, B.K.; White, J.M.; Tamm, L.K. HIV virions sense plasma membrane heterogeneity for cell entry. Sci. Adv. 2017, 3, e1700338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Coomer, C.A.; Carlon-Andres, I.; Iliopoulou, M.; Dustin, M.L.; Compeer, E.B.; Compton, A.A.; Padilla-Parra, S. Single-cell glycolytic activity regulates membrane tension and HIV-1 fusion. PLOS Pathog. 2020, 1–31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Miyauchi, K.; Marin, M.; Melikyan, G.B. Visualization of retrovirus uptake and delivery into acidic endosomes. Biochem. J. 2011, 434, 559–569. [Google Scholar] [CrossRef] [Green Version]
  48. Demirkhanyan, L.H.; Marin, M.; Padilla-Parra, S.; Zhan, C.; Miyauchi, K.; Jean-Baptiste, M.; Novitskiy, G.; Lu, W.; Melikyan, G.B. Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin. J. Biol. Chem. 2012, 287, 28821–28838. [Google Scholar] [CrossRef] [Green Version]
  49. Sood, C.; Marin, M.; Mason, C.S.; Melikyan, G.B. Visualization of content release from cell surface-attached single HIV-1 particles carrying an extra-viral fluorescent pH-sensor. PLoS ONE 2016, 11, 1–19. [Google Scholar] [CrossRef] [Green Version]
  50. Campbell, E.M.; Perez, O.; Melar, M.; Hope, T.J. Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology 2007, 360, 286–293. [Google Scholar] [CrossRef] [Green Version]
  51. Miesenböck, G.; De Angelis, D.A.; Rothman, J.E. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 1998. [Google Scholar] [CrossRef]
  52. Padilla-Parra, S.; Marin, M.; Gahlaut, N.; Suter, R.; Kondo, N.; Melikyan, G.B. Fusion of Mature HIV-1 Particles Leads to Complete Release of a Gag-GFP-Based Content Marker and Raises the Intraviral pH. PLoS ONE 2013, 8, e71002. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Chojnacki, J.; Waithe, D.; Carravilla, P.; Huarte, N.; Galiani, S.; Enderlein, J.; Eggeling, C. Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state. Nat. Commun. 2017, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Parasassi, T.; De Stasio, G.; Ravagnan, G.; Rusch, R.M.; Gratton, E. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys. J. 1991, 60, 179–189. [Google Scholar] [CrossRef] [Green Version]
  55. Urbančič, I.; Brun, J.; Shrestha, D.; Waithe, D.; Eggeling, C.; Chojnacki, J. Lipid composition but not curvature is the determinant factor for the low molecular mobility observed on the membrane of virus-like vesicles. Viruses 2018, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Carravilla, P.; Cruz, A.; Martin-Ugarte, I.; Oar-Arteta, I.R.; Torralba, J.; Apellaniz, B.; Pérez-Gil, J.; Requejo-Isidro, J.; Huarte, N.; Nieva, J.L. Effects of HIV-1 gp41-Derived Virucidal Peptides on Virus-like Lipid Membranes. Biophys. J. 2017, 113, 1301–1310. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Nakane, S.; Iwamoto, A.; Matsuda, Z. The V4 and V5 variable loops of HIV-1 envelope glycoprotein are tolerant to insertion of green fluorescent protein and are useful targets for labeling. J. Biol. Chem. 2015, 290, 15279–15291. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Wang, L.; Izadmehr, S.; Kamau, E.; Kong, X.P.; Chen, B.K. Sequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging. Retrovirology 2019, 16, 1–16. [Google Scholar] [CrossRef]
  59. Muranyi, W.; Malkusch, S.; Müller, B.; Heilemann, M.; Kräusslich, H.G. Super-Resolution Microscopy Reveals Specific Recruitment of HIV-1 Envelope Proteins to Viral Assembly Sites Dependent on the Envelope C-Terminal Tail. PLoS Pathog. 2013, 9. [Google Scholar] [CrossRef]
  60. Roy, N.H.; Chan, J.; Lambele, M.; Thali, M. Clustering and Mobility of HIV-1 Env at Viral Assembly Sites Predict Its Propensity To Induce Cell-Cell Fusion. J. Virol. 2013, 87, 7516–7525. [Google Scholar] [CrossRef] [Green Version]
  61. Lehmann, M.; Rocha, S.; Mangeat, B.; Blanchet, F.; Uji-i, H.; Hofkens, J.; Piguet, V. Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction. PLoS Pathog. 2011, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Chojnacki, J.; Staudt, T.; Glass, B.; Bingen, P.; Engelhardt, J.; Anders, M.; Schneider, J.; Muller, B.; Hell, S.W.; Krausslich, H.G.; et al. Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy. Science (80-.) 2012, 338, 524–528. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Iliopoulou, M.; Nolan, R.; Alvarez, L.; Watanabe, Y.; Coomer, C.A.; Jakobsdottir, G.M.; Bowden, T.A.; Padilla-Parra, S. A dynamic three-step mechanism drives the HIV-1 pre-fusion reaction. Nat. Struct. Mol. Biol. 2018, 25, 814–822. [Google Scholar] [CrossRef] [PubMed]
  64. Sok, D.; Burton, D.R. Recent progress in broadly neutralizing antibodies to HIV. Nat. Immunol. 2018. [Google Scholar] [CrossRef]
  65. Carravilla, P.; Chojnacki, J.; Rujas, E.; Insausti, S.; Largo, E.; Waithe, D.; Apellaniz, B.; Sicard, T.; Julien, J.-P.; Eggeling, C.; et al. Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions. Nat. Commun. 2019, 10, 78. [Google Scholar] [CrossRef]
  66. Ray, K.; Mengistu, M.; Lewis, G.K.; Lakowicz, J.R.; DeVico, A.L. Antigenic Properties of the HIV Envelope on Virions in Solution. J. Virol. 2014, 88, 1795–1808. [Google Scholar] [CrossRef] [Green Version]
  67. Agrawal, P.; DeVico, A.L.; Foulke, J.S.; Lewis, G.K.; Pazgier, M.; Ray, K. Stoichiometric Analyses of Soluble CD4 to Native-like HIV-1 Envelope by Single-Molecule Fluorescence Spectroscopy. Cell Rep. 2019, 29, 176–186.e4. [Google Scholar] [CrossRef] [Green Version]
  68. Carravilla, P.; Darré, L.; Oar-Arteta, I.R.; Vesga, A.G.; Rujas, E.; de las Heras-Martínez, G.; Domene, C.; Nieva, J.L.; Requejo-Isidro, J. The bilayer collective properties govern the interaction of an HIV-1 antibody with the viral membrane. Biophys. J. 2020, 118, 44–56. [Google Scholar] [CrossRef]
  69. Lin, C.W.; Ting, A.Y. Transglutaminase-catalyzed site-specific conjugation of small-molecule probes to proteins in vitro and on the surface of living cells. J. Am. Chem. Soc. 2006, 128, 4542–4543. [Google Scholar] [CrossRef] [Green Version]
  70. Zhou, Z.; Cironi, P.; Lin, A.J.; Xu, Y.; Hrvatin, S.; Golan, D.E.; Silver, P.A.; Walsh, C.T.; Yin, J. Genetically encoded short peptide tags for orthogonal labelling by Sfp and AcpS phosphopantetheinyl transferases. ACS Chem. Biol. 2007, 2, 337–346. [Google Scholar] [CrossRef]
  71. Munro, J.B.; Gorman, J.; Ma, X.; Zhou, Z.; Arthos, J.; Burton, D.R.; Koff, W.C.; Courter, J.R.; Smith, A.B.; Kwong, P.D.; et al. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science 2014, 346, 759–763. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Ma, X.; Lu, M.; Gorman, J.; Terry, D.S.; Hong, X.; Zhou, Z.; Zhao, H.; Altman, R.B.; Arthos, J.; Blanchard, S.C.; et al. HIV-1 env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations. Elife 2018, 7, 1–18. [Google Scholar] [CrossRef] [PubMed]
  73. Lu, M.; Ma, X.; Castillo-Menendez, L.R.; Gorman, J.; Alsahafi, N.; Ermel, U.; Terry, D.S.; Chambers, M.; Peng, D.; Zhang, B.; et al. Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET. Nature 2019, 568, 415–419. [Google Scholar] [CrossRef] [PubMed]
  74. Das, D.K.; Govindan, R.; Nikić-Spiegel, I.; Krammer, F.; Lemke, E.A.; Munro, J.B. Direct Visualization of the Conformational Dynamics of Single Influenza Hemagglutinin Trimers. Cell 2018, 174, 926–937.e12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Das, D.K.; Bulow, U.; Diehl, W.E.; Durham, N.D.; Senjobe, F.; Chandran, K.; Luban, J.; Munro, J.B. Conformational changes in the Ebola virus membrane fusion machine induced by pH, Ca2+, and receptor binding. PLoS Biol. 2020, 18, e3000626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Sakin, V.; Hanne, J.; Dunder, J.; Anders-Össwein, M.; Laketa, V.; Nikić, I.; Kräusslich, H.-G.; Lemke, E.A.; Müller, B. A Versatile Tool for Live-Cell Imaging and Super-Resolution Nanoscopy Studies of HIV-1 Env Distribution and Mobility. Cell Chem. Biol. 2017, 24, 635–645.e5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Oum, Y.H.; Desai, T.M.; Marin, M.; Melikyan, G.B. Click labeling of unnatural sugars metabolically incorporated into viral envelope glycoproteins enables visualization of single particle fusion. J. Virol. Methods 2016, 233, 62–71. [Google Scholar] [CrossRef] [Green Version]
  78. Lee, J.H.; Ozorowski, G.; Ward, A.B. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer. Science. 2016, 351, 1043–1048. [Google Scholar] [CrossRef] [Green Version]
  79. Pédelacq, J.D.; Cabantous, S.; Tran, T.; Terwilliger, T.C.; Waldo, G.S. Engineering and characterization of a superfolder green fluorescent protein. Nat. Biotechnol. 2006. [Google Scholar] [CrossRef]
  80. Chuang, G.Y.; Zhou, J.; Acharya, P.; Rawi, R.; Shen, C.H.; Sheng, Z.; Zhang, B.; Zhou, T.; Bailer, R.T.; Dandey, V.P.; et al. Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition. Structure 2019. [Google Scholar] [CrossRef] [Green Version]
  81. Booth, M.J.; Neil, M.A.A.; Wilson, T. Aberration correction for confocal imaging in refractive-index- mismatched media. J. Microsc. 1998. [Google Scholar] [CrossRef]
  82. Gould, T.J.; Burke, D.; Bewersdorf, J.; Booth, M.J. Adaptive optics enables 3D STED microscopy in aberrating specimens. Opt. Express 2012, 20, 20998. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Barbotin, A.; Galiani, S.; Urbančič, I.; Eggeling, C.; Booth, M.J. Adaptive optics allows STED-FCS measurements in the cytoplasm of living cells. Opt. Express 2019, 27, 23378–23395. [Google Scholar] [CrossRef] [PubMed]
  84. Gwosch, K.C.; Pape, J.K.; Balzarotti, F.; Hoess, P.; Ellenberg, J.; Ries, J.; Hell, S.W. MINFLUX nanoscopy delivers 3D multicolor nanometer resolution in cells. Nat. Methods 2020. [Google Scholar] [CrossRef] [PubMed]
  85. Danylchuk, D.I.; Moon, S.; Xu, K.; Klymchenko, A.S. Tailor-made switchable solvatochromic probes for live-cell super-resolution imaging of plasma membrane organization. Angew. Chemie 2019, 131, 15062–15066. [Google Scholar] [CrossRef]
  86. Spahn, C.; Grimm, J.B.; Lavis, L.D.; Lampe, M.; Heilemann, M. Whole-Cell, 3D, and Multicolor STED Imaging with Exchangeable Fluorophores. Nano Lett. 2019, 19, 500–505. [Google Scholar] [CrossRef] [Green Version]
  87. Sakin, V.; Paci, G.; Lemke, E.A.; Müller, B. Labeling of virus components for advanced, quantitative imaging analyses. FEBS Lett. 2016, 1896–1914. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Examples of fluorescent molecules employed on HIV membrane research. DiD and Laurdan are membrane dyes. Fluorescent lipid analogues of cholesterol (labelled with TF, TF-Chol), sphingomyelin (labelled with TF, TF-SM) and DPPE (labelled with ATTO647N-DPPE) are also shown.
Figure 1. Examples of fluorescent molecules employed on HIV membrane research. DiD and Laurdan are membrane dyes. Fluorescent lipid analogues of cholesterol (labelled with TF, TF-Chol), sphingomyelin (labelled with TF, TF-SM) and DPPE (labelled with ATTO647N-DPPE) are also shown.
Viruses 12 00348 g001
Figure 2. Structure of Env and previously employed labels. Env (magenta, PDB 5FUU [78]) is usually labelled in variable loops (V1-5, orange). Note that due to their disordered nature, a number of variable loop residues remain unresolved and are not depicted. Env glycans (grey sticks) can also be labelled by click chemistry [77]. Different labelling strategies have been employed to label Env, such as insertion of the fluorescent protein sfGFP (green, PDB 2B3P [79]) into variable loops, immunostaining by the 2G12 Fab (blue, PDB 6E5P [80]), or enzymatic incorporation of the organic dyes Cy3B (yellow) and Alexa Fluor 647-NHS ester (AF647, red). Note that up to three label units can be incorporated per Env protein.
Figure 2. Structure of Env and previously employed labels. Env (magenta, PDB 5FUU [78]) is usually labelled in variable loops (V1-5, orange). Note that due to their disordered nature, a number of variable loop residues remain unresolved and are not depicted. Env glycans (grey sticks) can also be labelled by click chemistry [77]. Different labelling strategies have been employed to label Env, such as insertion of the fluorescent protein sfGFP (green, PDB 2B3P [79]) into variable loops, immunostaining by the 2G12 Fab (blue, PDB 6E5P [80]), or enzymatic incorporation of the organic dyes Cy3B (yellow) and Alexa Fluor 647-NHS ester (AF647, red). Note that up to three label units can be incorporated per Env protein.
Viruses 12 00348 g002

Share and Cite

MDPI and ACS Style

Carravilla, P.; Nieva, J.L.; Eggeling, C. Fluorescence Microscopy of the HIV-1 Envelope. Viruses 2020, 12, 348.

AMA Style

Carravilla P, Nieva JL, Eggeling C. Fluorescence Microscopy of the HIV-1 Envelope. Viruses. 2020; 12(3):348.

Chicago/Turabian Style

Carravilla, Pablo, José L. Nieva, and Christian Eggeling. 2020. "Fluorescence Microscopy of the HIV-1 Envelope" Viruses 12, no. 3: 348.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop